Indutrade today signed an agreement to acquire all of the shares in Rubin Medical AB, Sweden, with annual sales of approximately SEK 100 million.
Rubin Medical is a supplier of medical technology products with a focus on diabetes therapy in Scandinavia. The main products are insulin pumps, infusion sets and other devices. The company also has a unique service concept featuring 24-hour customer support.
”Since our first acquisition in medical technology in 2008 we have grown from SEK 60 million to SEK 330 million in this segment”, says Johnny Alvarsson, President and CEO of Indutrade.
Possession will be transferred today, and the company will be part of Indutrade’s Industrial Components business area. The acquisition is expected to have a marginally positive impact on Indutrade’s earnings per share.
Stockholm, 16 April 2012
INDUTRADE AB (publ)
For further information, please contact:
Johnny Alvarsson, President and CEO, tel. +46 70 589 17 95.